Showing 2141-2160 of 7110 for: Cochrane Systematic Reviews Back
- Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease
Cochrane Systematic Reviews, 7-Dec-2010
Enteral feeding (tube feeding) is offered to many people with amyotrophic lateral sclerosis/motor neuron disease experiencing difficulty swallowing (dysphagia) and maintaining adequate nutritional intake leading to weight loss.
- Enteral tube feeding for cystic fibrosis
Cochrane Systematic Reviews, 13-Apr-2015
Enteral tube feeding is routinely used in many cystic fibrosis centres when oral dietary and supplement intake has failed to achieve an adequate nutritional status. The use of this method of feeding is assessed on an individual basis taking into considera
- Enteral tube feeding for older people with advanced dementia
Cochrane Systematic Reviews, 10-Feb-2009
The use of enteral tube feeding for patients with advanced dementia who have poor nutritional intake is common. In one US survey 34% of 186,835 nursing home residents with advanced cognitive impairment were tube fed. Potential benefits or harms of this pr
- Enteral versus parenteral nutrition for acute pancreatitis
Cochrane Systematic Reviews, 4-Oct-2010
Acute pancreatitis creates a catabolic stress state promoting a systemic inflammatory response and nutritional deterioration. Adequate supply of nutrients plays an important role in recovery. Total parenteral nutrition (TPN) has been standard practice for
- Environmental and behavioural interventions for reducing physical activity limitation in community-dwelling visually impaired older people
Cochrane Systematic Reviews, 16-May-2013
Impairment of vision is associated with a loss of function in activities of daily living. Avoidance of physical activity and consequent reduced functional capacity is common in older people with visual impairment and an important risk factor for falls. In
- Environmental sanitary interventions for preventing active trachoma
Cochrane Systematic Reviews, 10-Jan-2012
Trachoma is a major cause of avoidable blindness. It is responsible for about six million blind people worldwide, mostly in the poor communities of developing countries. One of the major strategies advocated for the control of the disease is the applicati
- Enzyme replacement and substrate reduction therapy for Gaucher disease
Cochrane Systematic Reviews, 13-Apr-2015
Gaucher disease, a rare disorder, is caused by inherited deficiency of the enzyme glucocerebrosidase. It is unique among the ultra-orphan disorders in that four treatments are currently approved by various regulatory authorities for use in routine clinica
- Enzyme replacement therapy for Anderson-Fabry disease
Cochrane Systematic Reviews, 12-Dec-2012
Anderson-Fabry disease is an X-linked defect of glycosphingolipid metabolism. Progressive renal insufficiency is a major source of morbidity, additional complications result from cardio- and cerebro-vascular involvement. Survival is reduced among affected
- Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI
Cochrane Systematic Reviews, 25-Feb-2016
Mucopolysaccharidosis type VI or Maroteaux-Lamy syndrome is a rare genetic disorder caused by the deficiency of arylsulphatase B. The resultant accumulation of dermatan sulphate causes lysosomal damage.
- Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)
Cochrane Systematic Reviews, 3-Feb-2016
Mucopolysaccharidosis II, also known as Hunter syndrome, is a rare, X-linked disease caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase, which catalyses a step in the catabolism of glycosaminoglycans. The glycosaminoglycans accumulate wi
- Enzyme replacement therapy with laronidase (Aldurazyme®) for treating mucopolysaccharidosis type I
Cochrane Systematic Reviews, 18-Jun-2019
Mucopolysaccharidosis type I can be classified as three clinical sub-types; Hurler syndrome, Hurler-Scheie syndrome and Scheie syndrome, with the scale of severity being such that Hurler syndrome is the most severe and Scheie syndrome the least severe. It
- Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes
Cochrane Systematic Reviews, 12-Dec-2014
Myasthenia is a condition in which neuromuscular transmission is affected by antibodies against neuromuscular junction components (autoimmune myasthenia gravis, MG; and neonatal myasthenia gravis, NMG) or by defects in genes for neuromuscular junction pro
- Epidermal growth factor receptor blockers for the treatment of ovarian cancer
Cochrane Systematic Reviews, 15-Oct-2018
This is an update of a previously published version of the review (Issue 10, 2011).
- Epidural analgesia for cardiac surgery
Cochrane Systematic Reviews, 1-Jul-2013
A combination of general anaesthesia (GA) with thoracic epidural analgesia (TEA) may have a beneficial effect on clinical outcomes by reducing the risk of perioperative complications after cardiac surgery.
- Epidural analgesia for pain relief following hip or knee replacement
Cochrane Systematic Reviews, 30-Jan-2014
Hip and knee replacement are common operative procedures to improve mobility and quality of life. Adequate pain relief is essential in the postoperative period to enable ambulation and initiation of physiotherapy. Lumbar epidural analgesia is a common mod
- Epidural blood patching for preventing and treating post-dural puncture headache
Cochrane Systematic Reviews, 22-Nov-2013
This is an update of a Cochrane Review first published in Issue 2, 2002. Dural puncture is a common procedure, but leakage of cerebrospinal fluid (CSF) from the resulting dural defect may cause post-dural puncture headache (PDPH) after the procedure, and
- Epidural local anaesthetics versus opioid-based analgesic regimens for postoperative gastrointestinal paralysis, PONV and pain after abdominal surgery
Cochrane Systematic Reviews, 5-Nov-2014
Gastrointestinal paralysis, nausea and vomiting, and pain, are major clinical problems following abdominal surgery. Anaesthetic and analgesic techniques that reduce pain and postoperative nausea and vomiting (PONV), and prevent or reduce postoperative ile
- Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery
Cochrane Systematic Reviews, 12-Jan-2016
Epidural analgesia offers greater pain relief compared to systemic opioid-based medications, but its effect on morbidity and mortality is unclear. This review was originally published in 2006 and was updated in 2012 and again in 2016.
- Epidural therapy for the treatment of severe pre‐eclampsia in non labouring women
Cochrane Systematic Reviews, 28-Nov-2017
Pre-eclampsia is a pregnancy-specific multi-organ disorder, which is characterised by hypertension and multisystem organ involvement and which has significant maternal and fetal morbidity and mortality. Failure of the placental vascular remodelling and re
- Epidural versus non-epidural or no analgesia in labour
Cochrane Systematic Reviews, 9-Nov-2011
Epidural analgesia is a central nerve block technique achieved by injection of a local anaesthetic close to the nerves that transmit pain and is widely used as a form of pain relief in labour. However, there are concerns regarding unintended adverse effec
